Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) also offer renal benefits for patients with type 2 diabetes (Granata et al., 2022; Chen et al., 2025). The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.